118 related articles for article (PubMed ID: 9831901)
1. Analysis of the influence of nucleotidases on the apparent activity of exogenous ATP and ADP at P2Y1 receptors.
Vigne P; Breittmayer JP; Frelin C
Br J Pharmacol; 1998 Oct; 125(4):675-80. PubMed ID: 9831901
[TBL] [Abstract][Full Text] [Related]
2. Agonist action of adenosine triphosphates at the human P2Y1 receptor.
Palmer RK; Boyer JL; Schachter JB; Nicholas RA; Harden TK
Mol Pharmacol; 1998 Dec; 54(6):1118-23. PubMed ID: 9855642
[TBL] [Abstract][Full Text] [Related]
3. P2Y1-receptors in human platelets which are pharmacologically distinct from P2Y(ADP)-receptors.
Fagura MS; Dainty IA; McKay GD; Kirk IP; Humphries RG; Robertson MJ; Dougall IG; Leff P
Br J Pharmacol; 1998 May; 124(1):157-64. PubMed ID: 9630355
[TBL] [Abstract][Full Text] [Related]
4. PPADS inhibits P2Y1 purinoceptors in rat brain capillary endothelial cells and in rat ileal myocytes by an indirect mechanism.
Vigne P; Pacaud P; Loirand G; Breittmayer JP; Frelin C
Biochem Biophys Res Commun; 1998 Mar; 244(2):332-5. PubMed ID: 9514922
[TBL] [Abstract][Full Text] [Related]
5. Diadenosine polyphosphates as antagonists of the endogenous P2Y(1) receptor in rat brain capillary endothelial cells of the B7 and B10 clones.
Vigne P; Breittmayer JP; Frelin C
Br J Pharmacol; 2000 Apr; 129(7):1506-12. PubMed ID: 10742308
[TBL] [Abstract][Full Text] [Related]
6. Dependence of P2-nucleotide receptor agonist-mediated endothelium-independent relaxation on ectonucleotidase activity and A2A-receptors in rat portal vein.
Guibert C; Loirand G; Vigne P; Savineau JP; Pacaud P
Br J Pharmacol; 1998 Apr; 123(8):1732-40. PubMed ID: 9605582
[TBL] [Abstract][Full Text] [Related]
7. Cytoprotection against oxidative stress-induced damage of astrocytes by extracellular ATP via P2Y1 receptors.
Shinozaki Y; Koizumi S; Ishida S; Sawada J; Ohno Y; Inoue K
Glia; 2005 Jan; 49(2):288-300. PubMed ID: 15494980
[TBL] [Abstract][Full Text] [Related]
8. ATP and UTP at low concentrations strongly inhibit bone formation by osteoblasts: a novel role for the P2Y2 receptor in bone remodeling.
Hoebertz A; Mahendran S; Burnstock G; Arnett TR
J Cell Biochem; 2002; 86(3):413-9. PubMed ID: 12210747
[TBL] [Abstract][Full Text] [Related]
9. Mechanical stimulation releases nucleotides that activate P2Y1 receptors to trigger neural reflex chloride secretion in guinea pig distal colon.
Cooke HJ; Xue J; Yu JG; Wunderlich J; Wang YZ; Guzman J; Javed N; Christofi FL
J Comp Neurol; 2004 Jan; 469(1):1-15. PubMed ID: 14689470
[TBL] [Abstract][Full Text] [Related]
10. Benzoyl ATP is an antagonist of rat and human P2Y1 receptors and of platelet aggregation.
Vigne P; Hechler B; Gachet C; Breittmayer JP; Frelin C
Biochem Biophys Res Commun; 1999 Mar; 256(1):94-7. PubMed ID: 10066429
[TBL] [Abstract][Full Text] [Related]
11. Agonist binding and Gq-stimulating activities of the purified human P2Y1 receptor.
Waldo GL; Harden TK
Mol Pharmacol; 2004 Feb; 65(2):426-36. PubMed ID: 14742685
[TBL] [Abstract][Full Text] [Related]
12. Stage-specific expression of P2Y receptors, ecto-apyrase, and ecto-5'-nucleotidase in myeloid leukocytes.
Clifford EE; Martin KA; Dalal P; Thomas R; Dubyak GR
Am J Physiol; 1997 Sep; 273(3 Pt 1):C973-87. PubMed ID: 9316419
[TBL] [Abstract][Full Text] [Related]
13. Plasma ectonucleotidases prevent desensitization of purinergic receptors in stored platelets: importance for platelet activity during thrombus formation.
Cauwenberghs S; Feijge MA; Hageman G; Hoylaerts M; Akkerman JW; Curvers J; Heemskerk JW
Transfusion; 2006 Jun; 46(6):1018-28. PubMed ID: 16734820
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of ATP-induced glutamate release by MRS2179 in cultured dorsal spinal cord astrocytes.
Zeng JW; Liu XH; He WJ; Du L; Zhang JH; Wu XG; Ruan HZ
Pharmacology; 2008; 82(4):257-63. PubMed ID: 18841035
[TBL] [Abstract][Full Text] [Related]
15. ATP derivatives are antagonists of the P2Y1 receptor: similarities to the platelet ADP receptor.
Hechler B; Vigne P; Léon C; Breittmayer JP; Gachet C; Frelin C
Mol Pharmacol; 1998 Apr; 53(4):727-33. PubMed ID: 9547364
[TBL] [Abstract][Full Text] [Related]
16. ADP acting on P2Y13 receptors is a negative feedback pathway for ATP release from human red blood cells.
Wang L; Olivecrona G; Götberg M; Olsson ML; Winzell MS; Erlinge D
Circ Res; 2005 Feb; 96(2):189-96. PubMed ID: 15604418
[TBL] [Abstract][Full Text] [Related]
17. Agonist concentration-dependent differential responsivity of a human platelet purinergic receptor: pharmacological and kinetic studies of aggregation, deaggregation and shape change responses mediated by the purinergic P2Y1 receptor in vitro.
Maayani S; Schwarz TE; Patel ND; Craddock-Royal BD; Tagliente TM
Platelets; 2003; 14(7-8):445-62. PubMed ID: 14713514
[TBL] [Abstract][Full Text] [Related]
18. ATP-stimulated ANP release through P1 receptor subtype.
Cao C; Piao FL; Han JH; Kim SZ; Kim SH
Regul Pept; 2005 Apr; 127(1-3):37-43. PubMed ID: 15680468
[TBL] [Abstract][Full Text] [Related]
19. Release and interconversion of P2 receptor agonists by human osteoblast-like cells.
Buckley KA; Golding SL; Rice JM; Dillon JP; Gallagher JA
FASEB J; 2003 Aug; 17(11):1401-10. PubMed ID: 12890693
[TBL] [Abstract][Full Text] [Related]
20. Secreted ADP plays a central role in thrombin-induced phospholipase D activation in human platelets.
Martinson EA; Scheible S; Marx-Grunwitz A; Presek P
Thromb Haemost; 1998 Dec; 80(6):976-81. PubMed ID: 9869170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
